JP2016516078A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516078A5
JP2016516078A5 JP2016503735A JP2016503735A JP2016516078A5 JP 2016516078 A5 JP2016516078 A5 JP 2016516078A5 JP 2016503735 A JP2016503735 A JP 2016503735A JP 2016503735 A JP2016503735 A JP 2016503735A JP 2016516078 A5 JP2016516078 A5 JP 2016516078A5
Authority
JP
Japan
Prior art keywords
antibody
bag3
use according
pharmaceutical composition
monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016503735A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516078A (ja
JP6475225B2 (ja
Filing date
Publication date
Priority claimed from IT000403A external-priority patent/ITMI20130403A1/it
Application filed filed Critical
Publication of JP2016516078A publication Critical patent/JP2016516078A/ja
Publication of JP2016516078A5 publication Critical patent/JP2016516078A5/ja
Application granted granted Critical
Publication of JP6475225B2 publication Critical patent/JP6475225B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016503735A 2013-03-18 2014-03-04 治療上の使用のための抗bag3抗体 Active JP6475225B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2013A000403 2013-03-18
IT000403A ITMI20130403A1 (it) 2013-03-18 2013-03-18 Anticorpi anti-bag3 per uso terapeutico
PCT/IB2014/059416 WO2014147503A2 (en) 2013-03-18 2014-03-04 Anti-bag3 antibodies for therapeutic use

Publications (3)

Publication Number Publication Date
JP2016516078A JP2016516078A (ja) 2016-06-02
JP2016516078A5 true JP2016516078A5 (https=) 2017-03-23
JP6475225B2 JP6475225B2 (ja) 2019-02-27

Family

ID=48227407

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016503735A Active JP6475225B2 (ja) 2013-03-18 2014-03-04 治療上の使用のための抗bag3抗体

Country Status (9)

Country Link
US (2) US20150329622A1 (https=)
EP (1) EP2976104B1 (https=)
JP (1) JP6475225B2 (https=)
KR (1) KR20150129649A (https=)
CN (1) CN104902927A (https=)
CA (1) CA2895472C (https=)
ES (2) ES2721935T3 (https=)
IT (1) ITMI20130403A1 (https=)
WO (1) WO2014147503A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131351A1 (it) 2013-08-07 2015-02-08 Biouniversa Srl Molecole leganti il recettore di bag3 per uso terapeutico.
ITUB20155097A1 (it) * 2015-11-05 2017-05-05 Biouniversa Srl Anticorpi umanizzati anti-BAG3
CN105769900A (zh) * 2016-03-22 2016-07-20 山西大学 Bag3基因在制备抗膀胱癌药物中的应用
IT201600111877A1 (it) * 2016-11-07 2018-05-07 Biouniversa Srl Anti-BAG3 antibodies in combination with inhibitors of immune check-point for therapeutic use
WO2021140173A1 (en) 2020-01-10 2021-07-15 Biouniversa S.R.L. Methods and uses for treating fibrotic solid tumors with bags inhibitors
CN114533877B (zh) * 2022-03-09 2023-07-04 上海交通大学医学院附属第九人民医院 Bag3抑制剂在制备治疗瘢痕产品中的用途
WO2026074330A1 (en) 2024-10-01 2026-04-09 Fibrosys S.R.L. Antibodies and diagnostic methods for detecting bag3 protein in clinical samples

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU774355B2 (en) * 1998-09-09 2004-06-24 Burnham Institute, The Novel bag proteins and nucleic acid molecules encoding them
EP1323733A1 (en) * 2001-12-28 2003-07-02 Arturo Leone BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
WO2009014759A2 (en) * 2007-07-25 2009-01-29 The Trustess Of Columbia University In The City Of New York Methods of inhibiting vzv replication and related compositions
IT1397083B1 (it) * 2009-12-04 2012-12-28 Biouniversa Srl Marcatore biochimico serico
EP2676966A1 (en) * 2012-06-19 2013-12-25 Biouniversa S.r.l. BAG3 as biochemical serum and tissue marker

Similar Documents

Publication Publication Date Title
JP2016516078A5 (https=)
JP2015534579A5 (https=)
JP2017530722A5 (https=)
JP2015526440A5 (https=)
JP2016515124A5 (https=)
JP2016529255A5 (https=)
JP2013173775A5 (https=)
HRP20200767T1 (hr) Humanizirana anti-humana cd19 protutijela i postupci uporabe
JP2017514461A5 (https=)
JP2020515247A5 (https=)
RU2013155695A (ru) Препараты антител против с-мет
JP2016502504A5 (https=)
JP2017501167A5 (https=)
JP2013538553A5 (https=)
JP2016508973A5 (https=)
JP2015534578A5 (https=)
JP2017523786A5 (https=)
JP2018521691A5 (https=)
JP2016507555A5 (https=)
JP2015519052A5 (https=)
JP2017528480A5 (https=)
JP2013227339A5 (https=)
AR091701A1 (es) Anticuerpos anti-cd22 e inmunoconjugados
JP2015522252A5 (https=)
JP2016502515A5 (https=)